Dunakeszi, Hungary

Mária Balogh



Average Co-Inventor Count = 12.9

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mária Balogh: Innovator in Adenosine A3 Ligands

Introduction

Mária Balogh is a notable inventor based in Dunakeszi, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of adenosine A3 receptor ligands. With a total of two patents to his name, Balogh's work has implications for pharmaceutical applications.

Latest Patents

Mária Balogh's latest patents include "Imidazoquinoline derivatives and their use as adenosine A3 ligands" and "Aminoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands." The first patent focuses on adenosine A3 receptor ligands of a specific general formula, emphasizing their potential as antagonists and their pharmaceutical compositions. The second patent describes compounds that serve as strong adenosine A3 receptor ligands, highlighting their structural variations and potential therapeutic uses.

Career Highlights

Balogh is currently associated with Sanofi-Aventis, a leading global pharmaceutical company. His work at Sanofi-Aventis has allowed him to further his research and development efforts in the field of adenosine receptor ligands. His innovative approach has contributed to advancements in drug development.

Collaborations

Mária Balogh has collaborated with notable colleagues such as László Balázs and Sándor Bátori. These collaborations have fostered a productive research environment, enhancing the quality and impact of their collective work.

Conclusion

Mária Balogh's contributions to the field of medicinal chemistry, particularly in the area of adenosine A3 receptor ligands, demonstrate his innovative spirit and dedication to advancing pharmaceutical science. His patents reflect a commitment to developing new therapeutic options for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…